Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Appendicitis01:19

Appendicitis

Appendicitis is an acute inflammatory condition of the vermiform appendix, most commonly caused by obstruction of its lumen. The appendix is a narrow, blind-ended pouch that extends from the cecum, making it particularly prone to obstruction. Causes include fecaliths, lymphoid hyperplasia (often after viral infections), parasites, tumors, or foreign bodies. This obstruction initiates a cascade of pathological changes.Luminal Obstruction and Early InflammationAfter obstruction, normal mucosal...
Appendicitis-I: Introduction01:22

Appendicitis-I: Introduction

The appendix, a small, narrow, blind tube extending from the inferior part of the cecum, is widely regarded as a vestigial organ, having lost much of its original function through evolution. Despite its diminished role, the appendix can become inflamed, a condition known as appendicitis.
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Pilot Study of Plasma Cell-Free DNA Fragmentomics in Gallbladder Cancer.

JHEP reports : innovation in hepatology·2026
Same author

KRAS inhibition is an effective therapy for appendiceal adenocarcinoma.

Journal of hematology & oncology·2026
Same author

ctxR: Utilities for interacting with the CTX APIs.

NAM journal·2026
Same author

Appendiceal Adenocarcinoma Cytoreduction Outcomes and Perioperative Serum Tumor Marker Levels.

JAMA network open·2026
Same author

KRAS inhibition is an effective therapy for appendiceal adenocarcinoma.

bioRxiv : the preprint server for biology·2026
Same author

Genomic analysis of T Cell receptors reveals lynch syndrome specific immune signatures.

Nature communications·2026

Related Experiment Video

Updated: May 11, 2026

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
08:51

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch

Published on: August 24, 2019

High-level microsatellite instability in appendiceal carcinomas.

Melissa W Taggart1, John Galbincea, Paul F Mansfield

  • 1Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. mwtaggar@mdanderson.org

The American Journal of Surgical Pathology
|May 8, 2013
PubMed
Summary
This summary is machine-generated.

Microsatellite instability-high (MSI-high) appendiceal cancers are rare, occurring in 2.8% of cases. This contrasts with colorectal cancers, where MSI-high is more common, and suggests MLH1 promoter methylation is not a typical cause in the appendix.

More Related Videos

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy
05:21

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy

Published on: October 6, 2014

Related Experiment Videos

Last Updated: May 11, 2026

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
08:51

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch

Published on: August 24, 2019

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy
05:21

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy

Published on: October 6, 2014

Area of Science:

  • Oncology
  • Gastroenterology
  • Molecular Biology

Background:

  • High-level microsatellite instability (MSI-high) is a hallmark of approximately 15% of colorectal adenocarcinomas (CRCs), often linked to MLH1 promoter methylation.
  • Familial cases, such as Lynch syndrome, account for a small fraction of CRCs.
  • MSI-high is notably rare in appendiceal adenocarcinomas, with limited prior reports.

Observation:

  • This study analyzed 108 appendiceal carcinomas for MSI status using immunohistochemistry and polymerase chain reaction.
  • Three cases (2.8%) were identified as MSI-high, and one case was MSI-low.
  • The MSI-high cases exhibited varied loss of DNA mismatch-repair protein expression (MLH1/PMS2 or MSH2/MSH6) and lacked MLH1 promoter methylation or BRAF mutations.

Findings:

  • The prevalence of MSI-high in appendiceal carcinomas was found to be 2.8% (3 out of 108).
  • MSI-high rates were 3.1% in invasive carcinomas not arising from goblet cell carcinoid tumors, and 0% in those arising from goblet cell carcinoid tumors.
  • The molecular mechanisms for MSI-high in appendiceal cancer appear distinct from the common MLH1 promoter methylation seen in colorectal cancer.

Implications:

  • The low frequency of MSI-high in appendiceal cancer suggests it is less common than in the right colon.
  • The findings indicate that MLH1 promoter hypermethylation is unlikely to be the primary driver of MSI-high in appendiceal adenocarcinomas.
  • Further research is needed to elucidate the specific molecular pathways driving MSI-high appendiceal cancers.